Patents by Inventor Geoffrey C. Dunbar

Geoffrey C. Dunbar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140024638
    Abstract: The present invention relates to (2S,3R)—N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions, and methods for treating schizophrenia.
    Type: Application
    Filed: January 17, 2012
    Publication date: January 23, 2014
    Applicant: TARGACEPT, INC.
    Inventors: Merouane Bencherif, Geoffrey C. Dunbar, David A. Hosford, Gregory J. Gatto, Terry Hauser, Kristen G. Jordan, Anthony Carl Segreti
  • Publication number: 20120190752
    Abstract: The present invention relates to exo-S-mecamylamine and the use of exo-S-mecamylamine in medical treatments.
    Type: Application
    Filed: July 12, 2010
    Publication date: July 26, 2012
    Applicant: Targacept Inc.
    Inventors: Geoffrey C. Dunbar, Jessica Beaver, Steven M. Toler
  • Patent number: 6312717
    Abstract: An improved method of treatment for anxiety and/or depression provides a quicker and more robust anxiolytic/antidepressant activity to a patient suffering from depression. The method comprises the concurrent administration of effective doses of certain azapirones, such as buspirone, given in a manner that suppresses formation of the 1-(2-pyrimidinyl)piperazine metabolite; and a 5-HT1A autosomal receptor antagonist, such as pindolol.
    Type: Grant
    Filed: June 14, 1999
    Date of Patent: November 6, 2001
    Assignee: Bristol-Myers Squibb Company
    Inventors: Perry B. Molinoff, Geoffrey C. Dunbar